Full Press Release Details
to Report Fourth Quarter and Fiscal 2018 Financial Results and Provide Business
Update on Tuesday, February 19
Call Scheduled for 8am Eastern Time
Aviv, Israel- February 7, 2019 - InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard Embolic
Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it
will host a conference call and webcast on Tuesday, February 19, 2019, to discuss financial results for the three and twelve months
ended December 31, 2018, and provide a corporate update.
February 19 @ 8:00am Eastern Time
| Within the US: | 877-451-6152 |
| Outside the US: | 201-389-0879 |
| Israel: | 1 809 406 247 |
| Conference ID: | 13687159 |
| Webcast: | http://public.viavid.com/index.php?id=133118 |
Available through March 5th:
| Domestic: | 844-512-2921 |
| International: | 412-317-6671 |
| Replay PIN: | 13687159 |
seeks to utilize its proprietary MicroNet technology to make its products the industry standard for treatment
of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes.
common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American
under the ticker symbol NSPR.WS.